Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
To determine the effectiveness of four different strength combinations of three approved
anti-hypertension therapies (olmesartan medoxomil, amlodipine, and hydrochlorothiazide) for
lowering blood pressure.